{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:23Z","timestamp":1790742023220,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T00:00:00Z","timestamp":1500681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12016-017-8629-0","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T01:44:00Z","timestamp":1500687840000},"page":"269-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review"],"prefix":"10.1007","volume":"54","author":[{"given":"Massimo","family":"Cugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,22]]},"reference":[{"issue":"9","key":"8629_CR1","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Card TR, Gulliford MC (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132(9):2166\u20132170. doi:\n10.1038\/jid.2012.130","journal-title":"J Invest Dermatol"},{"issue":"4","key":"8629_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.berh.2006.05.001","volume":"20","author":"J Levin","year":"2006","unstructured":"Levin J, Werth VP (2006) Skin disorders with arthritis. Best Pract Res Clin Rheumatol 20(4):809\u2013826. doi:\n10.1016\/j.berh.2006.05.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"8629_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3899\/jrheum.130977","volume":"41","author":"P Richette","year":"2014","unstructured":"Richette P, Molto A, Viguier M, Dawidowicz K, Hayem G, Nassif A, Wendling D, Aubin F, Liote F, Bachelez H (2014) Hidradenitis suppurativa associated with spondyloarthritis\u2014results from a multicenter national prospective study. J Rheumatol 41(3):490\u2013494. doi:\n10.3899\/jrheum.130977","journal-title":"J Rheumatol"},{"issue":"2","key":"8629_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183\u2013196. doi:\n10.1016\/j.immuni.2017.02.006","journal-title":"Immunity"},{"issue":"1","key":"8629_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cei.12394","volume":"178","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome. Clin Exp Immunol 178(1):48\u201356. doi:\n10.1111\/cei.12394","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"8629_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.clindermatol.2013.11.004","volume":"32","author":"L Prat","year":"2014","unstructured":"Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M (2014) Neutrophilic dermatoses as systemic diseases. Clin Dermatol 32(3):376\u2013388. doi:\n10.1016\/j.clindermatol.2013.11.004","journal-title":"Clin Dermatol"},{"issue":"6","key":"8629_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","volume":"55","author":"D Wallach","year":"2006","unstructured":"Wallach D, Vignon-Pennamen MD (2006) From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 55(6):1066\u20131071. doi:\n10.1016\/j.jaad.2006.07.016","journal-title":"J Am Acad Dermatol"},{"issue":"10055","key":"8629_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. doi:\n10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"1","key":"8629_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri.2016.124","volume":"17","author":"V Malmstrom","year":"2017","unstructured":"Malmstrom V, Catrina AI, Klareskog L (2017) The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol 17(1):60\u201375. doi:\n10.1038\/nri.2016.124","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"8629_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8629_CR11","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. doi:\n10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8629_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","volume":"53","author":"A Sayah","year":"2005","unstructured":"Sayah A, English JC 3rd (2005) Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 53(2):191\u2013209; quiz 210-192. doi:\n10.1016\/j.jaad.2004.07.023","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"8629_CR13","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1002\/art.24961","volume":"60","author":"C Stehlik","year":"2009","unstructured":"Stehlik C (2009) Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis. Arthritis Rheum 60(12):3524\u20133530. doi:\n10.1002\/art.24961","journal-title":"Arthritis Rheum"},{"key":"8629_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519\u2013550. doi:\n10.1146\/annurev.immunol.021908.132612","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"8629_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","volume":"13","author":"AI Catrina","year":"2017","unstructured":"Catrina AI, Svensson CI, Malmstrom V, Schett G, Klareskog L (2017) Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol 13(2):79\u201386. doi:\n10.1038\/nrrheum.2016.200","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"8629_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.clindermatol.2005.01.014","volume":"23","author":"S Ahmadi","year":"2005","unstructured":"Ahmadi S, Powell FC (2005) Pyoderma gangrenosum: uncommon presentations. Clin Dermatol 23(6):612\u2013620. doi:\n10.1016\/j.clindermatol.2005.01.014","journal-title":"Clin Dermatol"},{"issue":"6","key":"8629_CR17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2133.1997.tb01568.x","volume":"137","author":"P Driesch von den","year":"1997","unstructured":"von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137(6):1000\u20131005","journal-title":"Br J Dermatol"},{"issue":"217","key":"8629_CR18","first-page":"173","volume":"55","author":"FC Powell","year":"1985","unstructured":"Powell FC, Schroeter AL, Su WP, Perry HO (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55(217):173\u2013186","journal-title":"Q J Med"},{"issue":"2","key":"8629_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000018452","volume":"201","author":"F Gay-Crosier","year":"2000","unstructured":"Gay-Crosier F, Dayer JM, Chavaz P, Hauser C (2000) Rheumatoid neutrophilic dermatitis\/Sweet\u2019s syndrome in a patient with seronegative rheumatoid arthritis. Dermatology 201(2):185\u2013187","journal-title":"Dermatology"},{"issue":"3 Suppl 2","key":"8629_CR20","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.jaad.2005.11.1089","volume":"54","author":"PS Yamauchi","year":"2006","unstructured":"Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM (2006) Treatment of recurrent Sweet\u2019s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 54(3 Suppl 2):S122\u2013S126. doi:\n10.1016\/j.jaad.2005.11.1089","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8629_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0738-081X(99)00129-7","volume":"18","author":"PR Cohen","year":"2000","unstructured":"Cohen PR, Kurzrock R (2000) Sweet\u2019s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18(3):265\u2013282","journal-title":"Clin Dermatol"},{"issue":"1","key":"8629_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clindermatol.2016.09.011","volume":"35","author":"R Wolf","year":"2017","unstructured":"Wolf R, Tuzun Y (2017) Acral manifestations of Sweet syndrome (neutrophilic dermatosis of the hands). Clin Dermatol 35(1):81\u201384. doi:\n10.1016\/j.clindermatol.2016.09.011","journal-title":"Clin Dermatol"},{"key":"8629_CR23","unstructured":"Ackerman AB (1978) Histologic diagnosis of inflammatory skin diseases: a method by pattern analysis. Lea & Febiger,"},{"issue":"4","key":"8629_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1067\/mjd.2001.119031","volume":"45","author":"TS Brown","year":"2001","unstructured":"Brown TS, Fearneyhough PK, Burruss JB, Callen JP (2001) Rheumatoid neutrophilic dermatitis in a woman with seronegative rheumatoid arthritis. J Am Acad Dermatol 45(4):596\u2013600. doi:\n10.1067\/mjd.2001.119031","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"8629_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archderm.1997.03890420097013","volume":"133","author":"HA Mashek","year":"1997","unstructured":"Mashek HA, Pham CT, Helm TN, Klaus M (1997) Rheumatoid neutrophilic dermatitis. Arch Dermatol 133(6):757\u2013760","journal-title":"Arch Dermatol"},{"issue":"9783","key":"8629_CR26","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137. doi:\n10.1016\/S0140-6736(11)60071-8","journal-title":"Lancet"},{"issue":"10","key":"8629_CR27","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218\u20131227","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8629_CR28","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyawa M (1990) Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 57(2):85\u201389","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"9","key":"8629_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2007.081364","volume":"67","author":"AM Sims","year":"2008","unstructured":"Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou CT, Doan T, Dowling A, Fialho RN, Gergely P, Gladman DD, Inman R, Kauppi M, Kaarela K, Laiho K, Maksymowych W, Pointon JJ, Rahman P, Reveille JD, Sorrentino R, Tuomilehto J, Vargas-Alarcon G, Wordsworth BP, Xu H, Brown MA, International Genetics of Ankylosing S (2008) Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 67(9):1305\u20131309. doi:\n10.1136\/ard.2007.081364","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8629_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/ard.2004.020800","volume":"63","author":"AL Tan","year":"2004","unstructured":"Tan AL, Marzo-Ortega H, O\u2019Connor P, Fraser A, Emery P, McGonagle D (2004) Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 63(9):1041\u20131045. doi:\n10.1136\/ard.2004.020800","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8629_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/ard.2004.023176","volume":"64","author":"H Haibel","year":"2005","unstructured":"Haibel H, Rudwaleit M, Listing J, Sieper J (2005) Open label trial of anakinra in active ankylosing spondylitis over 24\u00a0weeks. Ann Rheum Dis 64(2):296\u2013298. doi:\n10.1136\/ard.2004.023176","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8629_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/rheumatology\/kem302","volume":"47","author":"AN Bennett","year":"2008","unstructured":"Bennett AN, Tan AL, Coates LC, Emery P, Marzo-Ortega H, McGonagle D (2008) Sustained response to anakinra in ankylosing spondylitis. Rheumatology (Oxford) 47(2):223\u2013224. doi:\n10.1093\/rheumatology\/kem302","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8629_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD, Dahmen G, Wollenhaupt J, Schulze-Koops H, Kogan J, Ma S, Schumacher MM, Bertolino AP, Hueber W, Tak PP (2014) Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann Rheum Dis 73(2):349\u2013356. doi:\n10.1136\/annrheumdis-2012-202646","journal-title":"Ann Rheum Dis"},{"issue":"9664","key":"8629_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, Fretzin S, Kunynetz R, Kavanaugh A (2009) Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 373(9664):633\u2013640. doi:\n10.1016\/S0140-6736(09)60140-9","journal-title":"Lancet"},{"issue":"5","key":"8629_CR35","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA (2012) Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma\/delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum 64(5):1420\u20131429. doi:\n10.1002\/art.33507","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8629_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/art.23655","volume":"58","author":"C Jandus","year":"2008","unstructured":"Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P (2008) Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 58(8):2307\u20132317. doi:\n10.1002\/art.23655","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8629_CR37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128(5):1207\u20131211. doi:\n10.1038\/sj.jid.5701213","journal-title":"J Invest Dermatol"},{"issue":"1\u20132","key":"8629_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","volume":"359","author":"SP Raychaudhuri","year":"2012","unstructured":"Raychaudhuri SP, Raychaudhuri SK, Genovese MC (2012) IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem 359(1\u20132):419\u2013429. doi:\n10.1007\/s11010-011-1036-6","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"8629_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"A Maghraoui El","year":"2011","unstructured":"El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554\u2013560. doi:\n10.1016\/j.ejim.2011.06.006","journal-title":"Eur J Intern Med"},{"issue":"2","key":"8629_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB (2012) Clinical practice. Hidradenitis suppurativa. N Engl J Med 366(2):158\u2013164. doi:\n10.1056\/NEJMcp1014163","journal-title":"N Engl J Med"},{"issue":"6","key":"8629_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","volume":"149","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C (2013) Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol 149(6):762\u2013764. doi:\n10.1001\/jamadermatol.2013.2907","journal-title":"JAMA Dermatol"},{"issue":"1","key":"8629_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2133.2009.09430.x","volume":"162","author":"HH Zee van der","year":"2010","unstructured":"van der Zee HH, van der Woude CJ, Florencia EF, Prens EP (2010) Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol 162(1):195\u2013197. doi:\n10.1111\/j.1365-2133.2009.09430.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"8629_CR43","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH Zee van der","year":"2011","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164(6):1292\u20131298. doi:\n10.1111\/j.1365-2133.2011.10254.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"8629_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","volume":"71","author":"D Monnet","year":"2012","unstructured":"Monnet D, Kadi A, Izac B, Lebrun N, Letourneur F, Zinovieva E, Said-Nahal R, Chiocchia G, Breban M (2012) Association between the IL-1 family gene cluster and spondyloarthritis. Ann Rheum Dis 71(6):885\u2013890. doi:\n10.1136\/annrheumdis-2011-200439","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8629_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/bjd.14214","volume":"174","author":"AL Lima","year":"2016","unstructured":"Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174(3):514\u2013521. doi:\n10.1111\/bjd.14214","journal-title":"Br J Dermatol"},{"issue":"4","key":"8629_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","volume":"24","author":"C Ambarus","year":"2012","unstructured":"Ambarus C, Yeremenko N, Tak PP, Baeten D (2012) Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory? Curr Opin Rheumatol 24(4):351\u2013358. doi:\n10.1097\/BOR.0b013e3283534df4","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"8629_CR47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1440-0960.1989.tb00402.x","volume":"30","author":"TA Delaney","year":"1989","unstructured":"Delaney TA, Clay CD, Randell PL (1989) The bowel-associated dermatosis\u2014arthritis syndrome. Australas J Dermatol 30(1):23\u201327","journal-title":"Australas J Dermatol"},{"issue":"1","key":"8629_CR48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-3083.2004.00712.x","volume":"18","author":"MC Brouard","year":"2004","unstructured":"Brouard MC, Chavaz P, Borradori L (2004) Acute pustulosis of the legs in diverticulitis with sigmoid stenosis: an overlap between bowel-associated dermatosis-arthritis syndrome and pustular pyoderma gangrenosum. J Eur Acad Dermatol Venereol 18(1):89\u201392","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"8629_CR49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0733-8635(02)00006-2","volume":"20","author":"JP Callen","year":"2002","unstructured":"Callen JP (2002) Neutrophilic dermatoses. Dermatol Clin 20(3):409\u2013419","journal-title":"Dermatol Clin"},{"issue":"3","key":"8629_CR50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-75-3-377","volume":"75","author":"JW Shagrin","year":"1971","unstructured":"Shagrin JW, Frame B, Duncan H (1971) Polyarthritis in obese patients with intestinal bypass. Ann Intern Med 75(3):377\u2013380","journal-title":"Ann Intern Med"},{"issue":"4","key":"8629_CR51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2133.1981.tb00774.x","volume":"105","author":"C Kennedy","year":"1981","unstructured":"Kennedy C (1981) The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity. Br J Dermatol 105(4):425\u2013435","journal-title":"Br J Dermatol"},{"issue":"1","key":"8629_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1381\/096089204772787446","volume":"14","author":"GH Slater","year":"2004","unstructured":"Slater GH, Kerlin P, Georghiou PR, Fielding GA (2004) Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg 14(1):133\u2013135. doi:\n10.1381\/096089204772787446","journal-title":"Obes Surg"},{"issue":"5 Pt 1","key":"8629_CR53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(86)70095-9","volume":"14","author":"CH Dicken","year":"1986","unstructured":"Dicken CH (1986) Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass. J Am Acad Dermatol 14(5 Pt 1):792\u2013796","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"8629_CR54","first-page":"CS97","volume":"13","author":"L Prpic-Massari","year":"2007","unstructured":"Prpic-Massari L, Kastelan M, Brajac I, Cabrijan L, Zamolo G, Massari D (2007) Bowel-associated dermatosis-arthritis syndrome in a patient with appendicitis. Med Sci Monit 13(8):CS97\u2013C100","journal-title":"Med Sci Monit"},{"issue":"2","key":"8629_CR55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12016-012-8351-x","volume":"45","author":"AV Marzano","year":"2013","unstructured":"Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet\u2019s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202\u2013210. doi:\n10.1007\/s12016-012-8351-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8629_CR56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00005792-198003000-00003","volume":"59","author":"PJ Holt","year":"1980","unstructured":"Holt PJ, Davies MG, Saunders KC, Nuki G (1980) Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 59(2):114\u2013133","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"8629_CR57","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/art.24433","volume":"60","author":"D Aletaha","year":"2009","unstructured":"Aletaha D, Funovits J, Breedveld FC, Sharp J, Segurado O, Smolen JS (2009) Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum 60(5):1242\u20131249. doi:\n10.1002\/art.24433","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8629_CR58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.49.2.135","volume":"49","author":"JM Nolla","year":"1990","unstructured":"Nolla JM, Juanola X, Valverde J, Roig-Escofet D, Pagerols X, Servitge O (1990) Arthritis in acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome). Ann Rheum Dis 49(2):135","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8629_CR59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.berh.2013.09.005","volume":"27","author":"FM McQueen","year":"2013","unstructured":"McQueen FM (2013) Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 27(4):499\u2013522. doi:\n10.1016\/j.berh.2013.09.005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"8629_CR60","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.1780390627","volume":"39","author":"I Olivieri","year":"1996","unstructured":"Olivieri I, Costa AM, Cantini F, Niccoli L, Marini R, Ferri S (1996) Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy. Arthritis Rheum 39(6):1062\u20131065","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8629_CR61","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1155\/2013\/726598","volume":"35","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli F, Castelli R, Gualtierotti R (2013) Rheumatoid factors: clinical applications. Dis Markers 35(6):727\u2013734. doi:\n10.1155\/2013\/726598","journal-title":"Dis Markers"},{"issue":"3","key":"8629_CR62","first-page":"187","volume":"54","author":"AM Chamot","year":"1987","unstructured":"Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 54(3):187\u2013196","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"1","key":"8629_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/sarh.2000.8371","volume":"30","author":"S Doornum Van","year":"2000","unstructured":"Van Doornum S, Barraclough D, McColl G, Wicks I (2000) SAPHO: rare or just not recognized? Semin Arthritis Rheum 30(1):70\u201377. doi:\n10.1053\/sarh.2000.8371","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"8629_CR64","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bjd.14691","volume":"175","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175(5):882\u2013891. doi:\n10.1111\/bjd.14691","journal-title":"Br J Dermatol"},{"issue":"7","key":"8629_CR65","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/rheumatology\/keu481","volume":"54","author":"HJ Liao","year":"2015","unstructured":"Liao HJ, Chyuan IT, Wu CS, Lin SW, Chen KH, Tsai HF, Hsu PN (2015) Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford) 54(7):1317\u20131326. doi:\n10.1093\/rheumatology\/keu481","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8629_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11832-014-0627-7","volume":"9","author":"I Rukavina","year":"2015","unstructured":"Rukavina I (2015) SAPHO syndrome: a review. J Child Orthop 9(1):19\u201327. doi:\n10.1007\/s11832-014-0627-7","journal-title":"J Child Orthop"},{"issue":"8","key":"8629_CR67","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/rheumatology\/ken185","volume":"47","author":"M Hurtado-Nedelec","year":"2008","unstructured":"Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, Grootenboer-Mignot S, Ruimy R, Meyer O, Hayem G (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47(8):1160\u20131167. doi:\n10.1093\/rheumatology\/ken185","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8629_CR68","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jid.2013.309","volume":"134","author":"M Qin","year":"2014","unstructured":"Qin M, Pirouz A, Kim MH, Krutzik SR, Garban HJ, Kim J (2014) Propionibacterium acnes induces IL-1beta secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol 134(2):381\u2013388. doi:\n10.1038\/jid.2013.309","journal-title":"J Invest Dermatol"},{"issue":"7","key":"8629_CR69","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/apm.12035","volume":"121","author":"B Sahdo","year":"2013","unstructured":"Sahdo B, Sarndahl E, Elgh F, Soderquist B (2013) Propionibacterium acnes activates caspase-1 in human neutrophils. APMIS 121(7):652\u2013663. doi:\n10.1111\/apm.12035","journal-title":"APMIS"},{"issue":"6","key":"8629_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/08916934.2014.906582","volume":"47","author":"D Firinu","year":"2014","unstructured":"Firinu D, Barca MP, Lorrai MM, Perra S, Cabras S, Muggianu E, Di Martino ML, Manconi PE, Del Giacco SR (2014) TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome. Autoimmunity 47(6):389\u2013394. doi:\n10.3109\/08916934.2014.906582","journal-title":"Autoimmunity"},{"issue":"2","key":"8629_CR71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0950-3579(94)80022-7","volume":"8","author":"MF Kahn","year":"1994","unstructured":"Kahn MF, Khan MA (1994) The SAPHO syndrome. Baillieres Clin Rheumatol 8(2):333\u2013362","journal-title":"Baillieres Clin Rheumatol"},{"issue":"3","key":"8629_CR72","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME (2012) The SAPHO syndrome. Semin Arthritis Rheum 42(3):254\u2013265. doi:\n10.1016\/j.semarthrit.2012.05.006","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"8629_CR73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0049-0172(99)80027-4","volume":"29","author":"G Hayem","year":"1999","unstructured":"Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, Kahn MF, Meyer O (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29(3):159\u2013171","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"8629_CR74","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s003300050476","volume":"8","author":"J Freyschmidt","year":"1998","unstructured":"Freyschmidt J, Sternberg A (1998) The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 8(5):807\u2013812. doi:\n10.1007\/s003300050476","journal-title":"Eur Radiol"},{"issue":"8","key":"8629_CR75","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s10620-013-2653-6","volume":"58","author":"JE Naves","year":"2013","unstructured":"Naves JE, Cabre E, Manosa M, Grados D, Olive A, Domenech E (2013) A systematic review of SAPHO syndrome and inflammatory bowel disease association. Dig Dis Sci 58(8):2138\u20132147. doi:\n10.1007\/s10620-013-2653-6","journal-title":"Dig Dis Sci"},{"issue":"8","key":"8629_CR76","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s10067-013-2251-1","volume":"32","author":"BK Kundu","year":"2013","unstructured":"Kundu BK, Naik AK, Bhargava S, Srivastava D (2013) Diagnosing the SAPHO syndrome: a report of three cases and review of literature. Clin Rheumatol 32(8):1237\u20131243. doi:\n10.1007\/s10067-013-2251-1","journal-title":"Clin Rheumatol"},{"issue":"7","key":"8629_CR77","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","volume":"72","author":"NM Lindor","year":"1997","unstructured":"Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72(7):611\u2013615. doi:\n10.1016\/S0025-6196(11)63565-9","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"8629_CR78","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11(8):961\u2013969","journal-title":"Hum Mol Genet"},{"issue":"4","key":"8629_CR79","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1086\/302866","volume":"66","author":"HB Yeon","year":"2000","unstructured":"Yeon HB, Lindor NM, Seidman JG, Seidman CE (2000) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66(4):1443\u20131448. doi:\n10.1086\/302866","journal-title":"Am J Hum Genet"},{"issue":"5","key":"8629_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10067-013-2436-7","volume":"33","author":"J Hsieh","year":"2014","unstructured":"Hsieh J, Kadavath S, Efthimiou P (2014) Can traumatic injury trigger psoriatic arthritis? A review of the literature. Clin Rheumatol 33(5):601\u2013608. doi:\n10.1007\/s10067-013-2436-7","journal-title":"Clin Rheumatol"},{"key":"8629_CR81","doi-asserted-by":"publisher","unstructured":"Cugno M, Borghi A, Marzano AV (2017) PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment. Am J Clin Dermatol 18(4):555\u2013562.\u00a0doi:\n10.1007\/s40257-017-0265-1","DOI":"10.1007\/s40257-017-0265-1"},{"issue":"4","key":"8629_CR82","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/1756-185X.12274","volume":"17","author":"S Donmez","year":"2014","unstructured":"Donmez S, Pamuk ON, Gedik M, KR A, Bulut G (2014) A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab. Int J Rheum Dis 17(4):471\u2013475. doi:\n10.1111\/1756-185X.12274","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"8629_CR83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/08916934.2013.873414","volume":"47","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Borghi A, Meroni PL, Crosti C, Cugno M (2014) Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity 47(3):146\u2013153. doi:\n10.3109\/08916934.2013.873414","journal-title":"Autoimmunity"},{"issue":"12","key":"8629_CR84","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10067-007-0733-8","volume":"26","author":"K Vandevyvere","year":"2007","unstructured":"Vandevyvere K, Luyten FP, Verschueren P, Lories R, Segaert S, Westhovens R (2007) Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. Clin Rheumatol 26(12):2205\u20132206. doi:\n10.1007\/s10067-007-0733-8","journal-title":"Clin Rheumatol"},{"issue":"6","key":"8629_CR85","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/archderm.144.6.817","volume":"144","author":"M Stichenwirth","year":"2008","unstructured":"Stichenwirth M, Riedl E, Pehamberger H, Tappeiner G (2008) Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? Arch Dermatol 144(6):817\u2013818. doi:\n10.1001\/archderm.144.6.817","journal-title":"Arch Dermatol"},{"issue":"6","key":"8629_CR86","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1684\/ejd.2012.1849","volume":"22","author":"N Kikuchi","year":"2012","unstructured":"Kikuchi N, Hiraiwa T, Ohashi T, Hanami Y, Satoh M, Takenoshita H, Yamamoto T (2012) Pyoderma gangrenosum possibly triggered by adalimumab. Eur J Dermatol 22(6):804\u2013805. doi:\n10.1684\/ejd.2012.1849","journal-title":"Eur J Dermatol"},{"issue":"5","key":"8629_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ddg.12032","volume":"11","author":"L Kowalzick","year":"2013","unstructured":"Kowalzick L, Bertolini J, Baumann C, Walther B, Truhm B, Eickenscheidt L (2013) Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis. J Dtsch Dermatol Ges 11(5):447\u2013449. doi:\n10.1111\/ddg.12032","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"8629_CR88","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","volume":"10","author":"D Wendling","year":"2014","unstructured":"Wendling D, Prati C (2014) Paradoxical effects of anti-TNF-alpha agents in inflammatory diseases. Expert Rev Clin Immunol 10(1):159\u2013169. doi:\n10.1586\/1744666X.2014.866038","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"8629_CR89","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2340\/00015555-2380","volume":"96","author":"M Akahoshi-Ikeda","year":"2016","unstructured":"Akahoshi-Ikeda M, Yoshizawa S, Motoshita J, Furue M, Takeuchi S (2016) A case of pyoderma gangrenosum in a patient with rheumatoid arthritis treated with abatacept. Acta Derm Venereol 96(6):822\u2013823. doi:\n10.2340\/00015555-2380","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"8629_CR90","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/ajd.12185","volume":"55","author":"SM Tiwari","year":"2014","unstructured":"Tiwari SM, Wood BA, Skender-Kalnenas T, Cook N (2014) A case of abatacept associated neutrophilic dermatosis and a review of the literature. Australas J Dermatol 55(3):214\u2013217. doi:\n10.1111\/ajd.12185","journal-title":"Australas J Dermatol"},{"issue":"4","key":"8629_CR91","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","volume":"31","author":"C Alvarez-Quiroga","year":"2011","unstructured":"Alvarez-Quiroga C, Abud-Mendoza C, Doniz-Padilla L, Juarez-Reyes A, Monsivais-Urenda A, Baranda L, Gonzalez-Amaro R (2011) CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol 31(4):588\u2013595. doi:\n10.1007\/s10875-011-9527-5","journal-title":"J Clin Immunol"},{"issue":"2","key":"8629_CR92","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/72323","volume":"6","author":"DE Anderson","year":"2000","unstructured":"Anderson DE, Bieganowska KD, Bar-Or A, Oliveira EM, Carreno B, Collins M, Hafler DA (2000) Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population. Nat Med 6(2):211\u2013214. doi:\n10.1038\/72323","journal-title":"Nat Med"},{"issue":"2","key":"8629_CR93","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","volume":"53","author":"J Reichrath","year":"2005","unstructured":"Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53(2):273\u2013283. doi:\n10.1016\/j.jaad.2004.10.006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8629_CR94","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","volume":"62","author":"J Miller","year":"2010","unstructured":"Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR (2010) Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 62(4):646\u2013654. doi:\n10.1016\/j.jaad.2009.05.030","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8629_CR95","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55(4):505\u2013509. doi:\n10.1136\/gut.2005.074815","journal-title":"Gut"},{"key":"8629_CR96","doi-asserted-by":"publisher","first-page":"h2958","DOI":"10.1136\/bmj.h2958","volume":"350","author":"AD Ormerod","year":"2015","unstructured":"Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC, Team UKDCTNsSG (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 350:h2958. doi:\n10.1136\/bmj.h2958","journal-title":"BMJ"},{"issue":"1","key":"8629_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOH.0000000000000100","volume":"22","author":"D Maalouf","year":"2015","unstructured":"Maalouf D, Battistella M, Bouaziz JD (2015) Neutrophilic dermatosis: disease mechanism and treatment. Curr Opin Hematol 22(1):23\u201329. doi:\n10.1097\/MOH.0000000000000100","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"8629_CR98","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","volume":"75","author":"KS Thomas","year":"2016","unstructured":"Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC, Team UKDCTNsSG (2016) Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study. J Am Acad Dermatol 75(5):940\u2013949. doi:\n10.1016\/j.jaad.2016.06.016","journal-title":"J Am Acad Dermatol"},{"issue":"3\u20134","key":"8629_CR99","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10354-016-0472-z","volume":"167","author":"AA Chokoeva","year":"2017","unstructured":"Chokoeva AA, Cardoso JC, Wollina U, Tchernev G (2017) Pyoderma gangrenosum\u2014a novel approach? Wien Med Wochenschr 167(3\u20134):58\u201365. doi:\n10.1007\/s10354-016-0472-z","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"8629_CR100","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161(5):1199\u20131201. doi:\n10.1111\/j.1365-2133.2009.09404.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"8629_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/2013.jamadermatol.717","volume":"149","author":"A Geusau","year":"2013","unstructured":"Geusau A, Mothes-Luksch N, Nahavandi H, Pickl WF, Wise CA, Pourpak Z, Ponweiser E, Eckhart L, Sunder-Plassmann R (2013) Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 149(2):209\u2013215. doi:\n10.1001\/2013.jamadermatol.717","journal-title":"JAMA Dermatol"},{"issue":"5","key":"8629_CR102","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/bjd.14037","volume":"173","author":"AG Kolios","year":"2015","unstructured":"Kolios AG, Maul JT, Meier B, Kerl K, Traidl-Hoffmann C, Hertl M, Zillikens D, Rocken M, Ring J, Facchiano A, Mondino C, Yawalkar N, Contassot E, Navarini AA, French LE (2015) Canakinumab in adults with steroid-refractory pyoderma gangrenosum. Br J Dermatol 173(5):1216\u20131223. doi:\n10.1111\/bjd.14037","journal-title":"Br J Dermatol"},{"issue":"4","key":"8629_CR103","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","volume":"139","author":"K Krause","year":"2017","unstructured":"Krause K, Tsianakas A, Wagner N, Fischer J, Weller K, Metz M, Church MK, Maurer M (2017) Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J Allergy Clin Immunol 139(4):1311\u20131320. doi:\n10.1016\/j.jaci.2016.07.041","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8629_CR104","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","volume":"22","author":"DS Stichweh","year":"2005","unstructured":"Stichweh DS, Punaro M, Pascual V (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22(3):262\u2013265. doi:\n10.1111\/j.1525-1470.2005.22320.x","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"8629_CR105","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","volume":"16","author":"ND Tofteland","year":"2010","unstructured":"Tofteland ND, Shaver TS (2010) Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol 16(5):244\u2013245. doi:\n10.1097\/RHU.0b013e3181e969b9","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"8629_CR106","first-page":"452","volume":"30","author":"H Lee","year":"2012","unstructured":"Lee H, Park SH, Kim SK, Choe JY, Park JS (2012) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clin Exp Rheumatol 30(3):452","journal-title":"Clin Exp Rheumatol"},{"issue":"27","key":"8629_CR107","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000187","volume":"93","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, Grossi A, De Simone C, Borghi OM, Meroni PL, Crosti C, Cugno M (2014) Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 93(27):e187. doi:\n10.1097\/MD.0000000000000187","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"8629_CR108","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C, Group ES, Group FS (2014) Secukinumab in plaque psoriasis\u2014results of two phase 3 trials. N Engl J Med 371(4):326\u2013338. doi:\n10.1056\/NEJMoa1314258","journal-title":"N Engl J Med"},{"issue":"7","key":"8629_CR109","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.cell.2016.11.044","volume":"167","author":"PR Burkett","year":"2016","unstructured":"Burkett PR, Kuchroo VK (2016) IL-17 blockade in psoriasis. Cell 167(7):1669. doi:\n10.1016\/j.cell.2016.11.044","journal-title":"Cell"},{"issue":"5","key":"8629_CR110","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00431-015-2668-4","volume":"175","author":"MP Cavalcante","year":"2016","unstructured":"Cavalcante MP, Brunelli JB, Miranda CC, Novak GV, Malle L, Aikawa NE, Jesus AA, Silva CA (2016) CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature\u2014a rare case with a novel mutation. Eur J Pediatr 175(5):735\u2013740. doi:\n10.1007\/s00431-015-2668-4","journal-title":"Eur J Pediatr"},{"issue":"11","key":"8629_CR111","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s12272-011-1109-9","volume":"34","author":"S Mitragotri","year":"2011","unstructured":"Mitragotri S, Yoo JW (2011) Designing micro- and nano-particles for treating rheumatoid arthritis. Arch Pharm Res 34(11):1887\u20131897. doi:\n10.1007\/s12272-011-1109-9","journal-title":"Arch Pharm Res"},{"issue":"2","key":"8629_CR112","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jbspin.2016.01.008","volume":"84","author":"F Simonetta","year":"2017","unstructured":"Simonetta F, Allali D, Roux-Lombard P, Chizzolini C (2017) Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab. Joint Bone Spine 84(2):235\u2013236. doi:\n10.1016\/j.jbspin.2016.01.008","journal-title":"Joint Bone Spine"},{"issue":"11","key":"8629_CR113","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/rheumatology\/keu369","volume":"53","author":"T Kraaij","year":"2014","unstructured":"Kraaij T, Huizinga TW, Rabelink TJ, Teng YK (2014) Belimumab after rituximab as maintenance therapy in lupus nephritis. Rheumatology (Oxford) 53(11):2122\u20132124. doi:\n10.1093\/rheumatology\/keu369","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8629-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T08:10:45Z","timestamp":1535011845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8629-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,22]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["8629"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8629-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,22]]}}}